In this study, a magnetic-driven hydrogel microrobots carried the PRMT5 inhibitor, EPZ015666 (Chan-Penebre et al., 2015), which was synthesized to evaluate a precision synthetic lethality nanodrug for osteosarcoma treatment. Here, PRMT5 is linked to osteosarcoma.